Journal
JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/jcm10030492
Keywords
classification; endocrine; hepatocellular carcinoma (HCC); LDE system; NAFLD; MAFLD; metabolic syndrome; psycho-depression; virus-associated fatty liver disease (VAFLD)
Categories
Ask authors/readers for more resources
As our understanding of fatty liver syndromes and their association with metabolic syndrome improves, the transition from NAFLD to MAFLD is approaching. However, a premature change in terminology may not necessarily address major unmet needs.
Our understanding of fatty liver syndromes and their relationship with the metabolic syndrome has improved over recent decades and, paralleling this, we are now at the dawn of the NAFLD (nonalcoholic fatty liver disease) to MAFLD (metabolic-associated fatty liver disease) transition. The pitfalls of NAFLD diagnosis, together with disappointing results in therapeutic trials, and the inconsistencies and risks inherent in a negative definition (such as nonalcoholic) as opposed to a positive one (i.e., metabolic) are predicted to facilitate the proposed renaming of NAFLD to MAFLD. However, a premature change of terminology would not necessarily address major unmet needs in this area, and may even become counterproductive. As an aid to selecting more homogeneous cohorts of patients, I propose the LDE (Liver, Determinants, Extra-hepatic) classification system which, in principle, may help to assess the natural course of disease as well as the efficacy of novel drugs in patients with NAFLD/MAFLD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available